Constellation Pharmaceuticals (CNST) PT Lowered to $48 at BMO Capital

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Constellation Pharmaceuticals (CNST) PT Lowered to $48 at BMO Capital

Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update

May 10, 2021 7:00 AM EDT

Dosing underway in the Phase 3 MANIFEST-2 clinical trialRecommended Phase 2 dose determined for CPI-0209 and first patient dosed in the Phase 2 expansion cohortsUpcoming data presentation at ASCO supports the best-in-class target engagement potential of CPI-0209

CAMBRIDGE, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced its first-quarter 2021 financial results. The Company... More